CARL ZEISS MEDITEC ADR 1 (F:AFXA) — Stock Price
CARL ZEISS MEDITEC ADR 1 (F:AFXA) is currently trading at €26.60 EUR, down 1.48% today. Over the past 52 weeks, shares have ranged between €22.40 and €65.00. This page tracks CARL ZEISS MEDITEC ADR 1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CARL ZEISS MEDITEC ADR 1 market cap and net worth.
CARL ZEISS MEDITEC ADR 1 (AFXA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CARL ZEISS MEDITEC ADR 1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
CARL ZEISS MEDITEC ADR 1 Income Statement — Revenue, Profit & Earnings by Year
CARL ZEISS MEDITEC ADR 1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €2.23 Billion | €2.07 Billion | €2.09 Billion | €1.90 Billion |
| Cost of Revenue | €1.05 Billion | €977.50 Million | €883.53 Million | €775.24 Million |
| Gross Profit | €1.18 Billion | €1.09 Billion | €1.21 Billion | €1.13 Billion |
| Research & Development | €326.27 Million | €343.09 Million | €349.28 Million | €291.37 Million |
| SG&A | €626.52 Million | €569.21 Million | €504.06 Million | €438.06 Million |
| Total Operating Expenses | €2.00 Billion | €1.87 Billion | €1.74 Billion | €1.51 Billion |
| Operating Income | €223.32 Million | €194.45 Million | €348.12 Million | €396.88 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €26.62 Million | €29.42 Million | €15.25 Million | €9.59 Million |
| Income Before Tax | €193.89 Million | €240.87 Million | €412.56 Million | €403.49 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €141.21 Million | €178.73 Million | €290.40 Million | €293.91 Million |
CARL ZEISS MEDITEC ADR 1 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CARL ZEISS MEDITEC ADR 1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €3.40 Billion | €3.39 Billion | €3.03 Billion | €2.82 Billion |
| Total Current Assets | €1.27 Billion | €1.21 Billion | €1.91 Billion | €1.79 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €209.01 Million | €209.05 Million | €196.92 Million | €197.80 Million |
| Inventory | €496.98 Million | €536.16 Million | €519.62 Million | €382.75 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €969.74 Million | €982.50 Million | €415.78 Million | €429.65 Million |
| Total Liabilities | €1.28 Billion | €1.34 Billion | €860.02 Million | €792.73 Million |
| Total Current Liabilities | €543.81 Million | €568.84 Million | €561.65 Million | €539.32 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | — | — | — |
| Total Stockholder Equity | €2.12 Billion | €2.04 Billion | €2.16 Billion | €2.02 Billion |
| Retained Earnings | €1.58 Billion | €1.49 Billion | €1.41 Billion | €1.21 Billion |
CARL ZEISS MEDITEC ADR 1 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CARL ZEISS MEDITEC ADR 1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €209.86 Million | €247.32 Million | €250.86 Million | €188.20 Million |
| Capital Expenditures | €76.59 Million | €152.20 Million | €113.86 Million | €81.97 Million |
| Free Cash Flow | €133.26 Million | €95.11 Million | €137.00 Million | €106.23 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | €52.52 Million | €98.20 Million | €98.39 Million | €80.50 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €126.38 Million | €132.77 Million | €74.06 Million | €69.77 Million |
| Change in Cash | €6.98 Million | €9.68 Million | €2.87 Million | €290.00K |
CARL ZEISS MEDITEC ADR 1 Earnings History — EPS Actual vs. Analyst Estimates
Track CARL ZEISS MEDITEC ADR 1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Feb 10, 2026 | — | — | — |
| May 06, 2025 | — | — | — |
| Feb 07, 2025 | — | — | — |